Generic placeholder image

Current Women`s Health Reviews

Editor-in-Chief

ISSN (Print): 1573-4048
ISSN (Online): 1875-6581

Editorial

Women’s Health and CRISPR: Novel Cervical Cancer, Endometrial Cancer, Condyloma, Endometriosis, Fibroids and PCOS Diagnostic and Treatment Tools with CRISPR Nucleic Acid Approaches

Author(s): John Yeh

Volume 18, Issue 3, 2022

Published on: 25 April, 2022

Article ID: e250422204019 Pages: 2

DOI: 10.2174/157340481803220425132932

Open Access Journals Promotions 2
[1]
Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014 Nov 28; 346(6213): 1258096.
[http://dx.doi.org/10.1126/science.1258096] [PMID: 25430774]
[2]
Doudna JA. The promise and challenge of therapeutic genome editing. Nature. 2020 Feb; 578(7794): 229-236. Epub 2020 Feb 12.
[http://dx.doi.org/10.1038/s41586-020-1978-5] [PMID: 32051598]
[3]
Uyhazi KE, Bennett J. A CRISPR view of the 2020 Nobel Prize in Chemistry. J Clin Invest 2021; 131(1): e145214.
[http://dx.doi.org/10.1172/JCI145214]
[4]
Abudayyeh O, Gootenberg J, Essletzbichler P, et al. RNA targeting with CRISPR–Cas13. Nature 2017; 550: 280-4.
[http://dx.doi.org/10.1038/nature24049]
[5]
Zhang W, Liu Y, Zhou X, Zhao R, Wang H. Applications of CRISPR-Cas9 in gynecological cancer research. Clin Genet 2020; 97: 827-34.
[http://dx.doi.org/10.1111/cge.13717]
[6]
Zhen S, Li X. Oncogenic Human Papillomavirus: Application of CRISPR/Cas9 Therapeutic Strategies for Cervical Cancer. Cell Physiol Biochem 2017; 44: 2455-66.
[http://dx.doi.org/10.1159/000486168]
[7]
Kavlashvili T, Jia Y, Dai D, Meng X, Thiel KW, Leslie KK, et al. (2016) Inverse Relationship between Progesterone Receptor and Myc in Endometrial Cancer. PLoS ONE 11(2): e0148912.
[http://dx.doi.org/10.1371/journal.pone.0148912]
[8]
Liu YC, Cai ZM, Zhang XJ. Reprogrammed CRISPR-Cas9 targeting the conserved regions of HPV6/11 E7 genes inhibits proliferation and induces apoptosis in E7-transformed keratinocytes. Asian J Androl 2016; 18: 475-9.
[http://dx.doi.org/10.4103/1008-682X.157399]
[9]
Baker C, Hayden MS. Gene editing in dermatology: Harnessing CRISPR for the treatment of cutaneous disease [version 1; peer review: 2 approved] F1000Research 2020, 9:281
[http://dx.doi.org/10.12688/f1000research.23185.1]
[10]
Sahin C, Mamillapalli R, Yi KW, Taylor HS. microRNA Let-7b: A Novel treatment for endometriosis. J Cell Mol Med 2018; 22(11): 5346-53.
[http://dx.doi.org/10.1111/jcmm.13807]
[11]
Tapmeier TT, Rahmioglu N, Lin J, et al. Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis. Sci Transl Med 2021; 13: eabd6469.
[http://dx.doi.org/10.1126/scitranslmed.abd6469]
[12]
Moyo MB, Parker JB, Chakravarti D. Altered chromatin landscape and enhancer engagement underlie transcriptional dysregulation in MED12 mutant uterine leiomyomas. Nature communications 2020; 11(1) [1019].
[http://dx.doi.org/10.1038/s41467-020-14701-6]
[13]
Machado-Lopez A, Simón C, Mas A. Molecular and Cellular Insights into the Development of Uterine Fibroids. Int. J. Mol. Sci. 2021, 22, 8483.
[http://dx.doi.org/10.3390/ijms22168483]
[14]
Zhou J, Jin X, Sheng Z, Zhang Z. miR-206 serves an important role in polycystic ovary syndrome through modulating ovarian granulosa cell proliferation and apoptosis. Exp Ther Med. 2021 Mar; 21(3): 179. Epub 2021 Jan 5.
[http://dx.doi.org/10.3892/etm.2021.9610] [PMID: 33500693] [PMCID: PMC7818533]
[15]
Chen Z, Yu HJ, Shi X, Warren CR, Lotta LA, Friesen M, Meissner TB, Langenberg C, Wabitsch M, Wareham N, et al. Functional screening of candidate causal genes for insulin resistance in human preadipocytes and adipocytes. Circ Res. 2020; 126:330–346.
[http://dx.doi.org/10.1161CIRCRESAHA.119.315246]

© 2024 Bentham Science Publishers | Privacy Policy